Dr. Aileen Marty, Infectious Disease Specialist and Professor at Florida International University, joins Bob Sirott to talk ...
Folks who want solid protection during the cold and flu season should get the influenza vaccine now, the U.S. Food and Drug ...
The so-called clinical hold is due to a single report of nerve damage in a patient who received the combination shot in a ...
The campaign “caused Americans to lose trust in the public health system,” House Energy and Commerce Committee Chair Cathy ...
Novavax’s plans for growth outside of its COVID program have been thrown into chaos after the FDA put the biooharma's flu ...
Novavax Inc.’s stock tumbled 16% early Wednesday after the company said the FDA has placed a clinical hold on its ...
The U.S. Food and Drug Administration has put a trial of Novavax’s COVID-influenza and its standalone flu vaccines on hold after a participant who took the combination shot reported nerve damage, the ...
The Food and Drug Administration (FDA) is placing a hold on Novavax's (NVAX) experimental flu-COVID vaccines after a patient ...
The hold, which was made in response to a serious adverse event report, could impact the company’s plans to start a Phase 3 ...
The clinical hold affects Novavax’s COVID-flu combo and standalone flu vaccines, which were on the cusp of Phase III testing.
The FDA has approved AstraZeneca’s FluMist Nasal Spray to be used outside a healthcare setting. “The new FDA release is for ...
FluMist is an efficacious and safely tolerated intranasal influenza vaccine. FluMist has gained approval from the FDA for ...